Preferred Label : Fluticasone Propionate, Salmeterol Xinafoate Drug Combination;
Origin ID : M000602345;
MeSH narrower concept(s)
- Related record
https://www.ema.europa.eu/en/medicines/human/EPAR/seffalair-spiromax
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
salmeterol and fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
adult
adolescent
asthma
administration, inhalation
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
Fluticasone
---
https://www.ema.europa.eu/en/medicines/human/EPAR/bropair-spiromax
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
salmeterol and fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
adult
adolescent
asthma
administration, inhalation
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
Fluticasone
---
https://www.has-sante.fr/jcms/p_3299688/fr/propionate-de-fluticasone/salmeterol-zentiva-salmeterol-/-propionate-de-fluticasone
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
glucocorticoids
Fluticasone Propionate
administration, inhalation
asthma
salmeterol and fluticasone
adrenergic beta-2 receptor agonists
adult
child
adolescent
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3299694/fr/propionate-de-fluticasone-salmeterol-biogaran-airmaster-salmeterol-/-propionate-de-fluticasone
2021
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
Fluticasone-Salmeterol Drug Combination
administration, inhalation
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate
bronchodilator agents
glucocorticoids
adrenergic beta-2 receptor agonists
asthma
pulmonary disease, chronic obstructive
adult
adolescent
child
salmeterol and fluticasone
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3107629/fr/salfluair-easyhaler
2019
false
false
false
France
Fluticasone-Salmeterol Drug Combination
insurance, health, reimbursement
treatment outcome
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
asthma
pulmonary disease, chronic obstructive
administration, inhalation
salmeterol and fluticasone
evaluation of the transparency committee
---
